Sign in
4

Changes in Ownership

Xilio Therapeutics, Inc. Filed Acc 0001193125-25-297207

Options or other derivatives

  • SVP, FINANCE AND ACCOUNTING acquired 231,700 shares (grant or award)
  • SVP, FINANCE AND ACCOUNTING returned 100,000 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Brennan Kevin M. · SVP, FINANCE AND ACCOUNTING

Table II: Derivative

7 lines
Date Transaction Shares Owned after D/I
2025-11-21 Grant or award : show line 1 in the form Stock Option (right to buy) +131,700 131,700 D
2025-11-21 Returned to the company : show line 2 in the form Stock Option (right to buy) −55,000 0 D
2025-11-21 Grant or award : show line 3 in the form Stock Option (right to buy) +55,000 55,000 D
2025-11-21 Returned to the company : show line 4 in the form Stock Option (right to buy) −25,000 0 D
2025-11-21 Grant or award : show line 5 in the form Stock Option (right to buy) +25,000 25,000 D
2025-11-21 Returned to the company : show line 6 in the form Stock Option (right to buy) −20,000 0 D
2025-11-21 Grant or award : show line 7 in the form Stock Option (right to buy) +20,000 20,000 D
Loading xslF345X05/ownership.xml…